SK bioscience

Aug 21, 2025

SK bioscience Discusses Further Collaboration with the Gates Foundation to Advance Global Health

May 21, 2025

SK bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine

May 20, 2025

IDT Biologika Accelerates Global Growth Through Strategic CDMO Partnership

Mar 12, 2025

SK bioscience Expands Influenza Vaccine Exports to Southern Hemisphere Market

Feb 25, 2025

SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

Dec 12, 2024

SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

Oct 23, 2024

SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia

Oct 08, 2024

Korea's SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions

Oct 02, 2024

South Korea's SK bioscience Completes Acquisition of Germany's CDMO IDT Biologika

Mar 07, 2024

SK bioscience Breaks Ground on Manufacturing Facility Expansion for Extending Product Pipeline

Feb 23, 2024

SK bioscience Receives WHO Prequalification for Typhoid Conjugate Vaccine